You’re assuming other companies will invest heavily and get their version to market within 3 years of seeing patent . Still need the technology and then Phase 1/2 and show at least equivalence . Time consuming and things go wrong . Easier to spend a few hundred $M to try and acquire LTP ?
- Forums
- ASX - By Stock
- LTP
- Ann: SPONTAN achieves positive clinical study results
Ann: SPONTAN achieves positive clinical study results, page-75
Featured News
Add LTP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.32 |
Change
-0.040(2.94%) |
Mkt cap ! $111.9M |
Open | High | Low | Value | Volume |
$1.36 | $1.36 | $1.28 | $527.1K | 402.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 2042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.300 |
2 | 1595 | 1.295 |
4 | 38944 | 1.290 |
4 | 11618 | 1.285 |
1 | 2420 | 1.280 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 2042 | 1 |
1.330 | 751 | 1 |
1.340 | 15200 | 1 |
1.350 | 12000 | 2 |
1.395 | 1250 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online